These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36206317)

  • 1. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer.
    Chambers LM; Esakov Rhoades EL; Bharti R; Braley C; Tewari S; Trestan L; Alali Z; Bayik D; Lathia JD; Sangwan N; Bazeley P; Joehlin-Price AS; Wang Z; Dutta S; Dwidar M; Hajjar A; Ahern PP; Claesen J; Rose P; Vargas R; Brown JM; Michener CM; Reizes O
    Cancer Res; 2022 Dec; 82(24):4654-4669. PubMed ID: 36206317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unintended Consequences of Antibiotic Therapy on the Microbiome Delivers a Gut Punch in Ovarian Cancer.
    Hawkins SM; Nephew KP
    Cancer Res; 2022 Dec; 82(24):4511-4512. PubMed ID: 36524345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer.
    Chambers LM; Kuznicki M; Yao M; Chichura A; Gruner M; Reizes O; Debernardo R; Rose PG; Michener C; Vargas R
    Gynecol Oncol; 2020 Dec; 159(3):699-705. PubMed ID: 32950250
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhan X; Zuo Q; Huang G; Qi Z; Wang Y; Zhu S; Zhong Y; Xiong Y; Chen T; Tan B
    Front Cell Infect Microbiol; 2023; 13():1236272. PubMed ID: 37818040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-derived metabolite 3-methylxanthine enhances cisplatin-induced apoptosis via dopamine receptor D1 in a mouse model of ovarian cancer.
    Mai Z; Han Y; Liang D; Mai F; Zheng H; Li P; Li Y; Ma C; Chen Y; Li W; Zhang S; Feng Y; Chen X; Wang Y
    mSystems; 2024 Jul; 9(7):e0130123. PubMed ID: 38899930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of gut microbiota improves the therapeutic efficacy of cancer nanomedicine.
    Prajnamitra RP; Cheng YY; Beh CY; Lu CY; Lin JH; Ruan SC; Chen SL; Chen HC; Yang RB; Hsieh PC
    Theranostics; 2022; 12(17):7390-7403. PubMed ID: 36438478
    [No Abstract]   [Full Text] [Related]  

  • 7. NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer.
    Nacarelli T; Fukumoto T; Zundell JA; Fatkhutdinov N; Jean S; Cadungog MG; Borowsky ME; Zhang R
    Cancer Res; 2020 Feb; 80(4):890-900. PubMed ID: 31857293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
    Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin as a regulator of development of the microbiota-gut-brain axis.
    Keogh CE; Kim DHJ; Pusceddu MM; Knotts TA; Rabasa G; Sladek JA; Hsieh MT; Honeycutt M; Brust-Mascher I; Barboza M; Gareau MG
    Brain Behav Immun; 2021 Jan; 91():437-450. PubMed ID: 33157256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota influenced the xenograft MC38 tumor growth potentially through interfering host lipid and amino acid metabolisms, basing on the integrated analysis of microbiome and metabolomics.
    Chen MH; Zhou J; Wu CY; Zhang W; Long F; Zhou SS; Xu JD; Wu J; Zou YT; Li SL; Shen H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1192():123136. PubMed ID: 35151210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells.
    Luo Y; Gui R
    J Gynecol Oncol; 2020 Sep; 31(5):e75. PubMed ID: 32808501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancer.
    Vidal A; Muñoz C; Guillén MJ; Moretó J; Puertas S; Martínez-Iniesta M; Figueras A; Padullés L; García-Rodriguez FJ; Berdiel-Acer M; Pujana MA; Salazar R; Gil-Martin M; Martí L; Ponce J; Molleví DG; Capella G; Condom E; Viñals F; Huertas D; Cuevas C; Esteller M; Avilés P; Villanueva A
    Clin Cancer Res; 2012 Oct; 18(19):5399-411. PubMed ID: 22896654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antibiotic cocktails on host immune status is dynamic and does not always correspond to changes in gut microbiota.
    Tao C; Zhang Q; Zeng W; Liu G; Shao H
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4995-5009. PubMed ID: 32303819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer's transgenic mice.
    Dodiya HB; Frith M; Sidebottom A; Cao Y; Koval J; Chang E; Sisodia SS
    Sci Rep; 2020 May; 10(1):8183. PubMed ID: 32424118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells.
    Wang Y; Yan C; Qi J; Liu C; Yu J; Wang H
    Mol Cell Biochem; 2022 Jan; 477(1):307-317. PubMed ID: 34716858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model.
    Gui QF; Lu HF; Zhang CX; Xu ZR; Yang YH
    Genet Mol Res; 2015 May; 14(2):5642-51. PubMed ID: 26125762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic-induced microbiome depletion improves LPS-induced acute lung injury via gut-lung axis.
    Hashimoto Y; Eguchi A; Wei Y; Shinno-Hashimoto H; Fujita Y; Ishima T; Chang L; Mori C; Suzuki T; Hashimoto K
    Life Sci; 2022 Oct; 307():120885. PubMed ID: 35981631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual mTORC1/2 inhibitor AZD2014 diminishes myeloid-derived suppressor cells accumulation in ovarian cancer and delays tumor growth.
    Pi R; Yang Y; Hu X; Li H; Shi H; Liu Y; Wang X; Tong A; Lu T; Wei Y; Zhao X; Wei X
    Cancer Lett; 2021 Dec; 523():72-81. PubMed ID: 34560229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells.
    Poursheikhani A; Yousefi H; Tavakoli-Bazzaz J; Seyed H G
    Iran Biomed J; 2020 Nov; 24(6):370-8. PubMed ID: 32660222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.